Table 1 Participant demographic and clinical characteristics at enrolment
Total enrolled (n = 169) | |
|---|---|
Age; median (IQR) | 23 (5–36) |
Male; n (%) | 75 (44) |
Febrile subjects (≧37.5); n (%) | 33 (19.8) |
Duration of fever (days); median (IQR) | 3 (2–3) |
Having chronic conditions; n (%) | 13 (7.7) |
Took antimalarials in the last one month; n (%) | 13 (7.7) |
Travelled in the last 3 months; n (%) | 13 (7.7) |
Slept under a bed net in previous night; n (%) | 155 (91.7) |
Covered by IRS programme for the last one year; n (%) | 119 (70.4) |
Enrolled in RTS,S vaccine trial; n (%) | 3 (1.9) |
Pregnancy; n (% of total female) | 4 (2.4) |
Haematological parameters* | |
White blood cell (103/μL); median (IQR) | 5.93 (4.82–8.93) |
Red blood cell (106/μL); median (IQR) | 5.04 (4.67–5.46) |
Haemoglobin (g/dL); median (IQR) | 13.1 (11.5–14.2) |
Anaemia (Hb < 11 g/dL); n (%) | 34 (20.1) |
Haematocrit (%); median (IQR) | 39.8 (34.6–43.1) |
Platelets (103/μL); median (IQR) | 256 (197–364) |
Thrombocytopenia (< 150 × 103/μL); n (%) | 14 (8.3) |